Sartorius Stedim Biotech (DIM.PA)

Every figure this model derived for DIM.PA, the value it took, and the element in the company's own XBRL it was read from — so any of it can be checked against the filing rather than taken on trust. As at 2025-12-31.

The figures, and where each came from

This is the part no other screener shows. Each figure below names the XBRL element it was read from, so it can be checked against the filing itself.

FigureValueXBRL tagAs at
cash 426,100,000 CashAndCashEquivalents 2026-01-01
current assets 1,441,200,000 CurrentAssets 2026-01-01
current liabilities 1,412,100,000 CurrentLiabilities 2026-01-01
equity 4,090,500,000 EquityAttributableToOwnersOfParent 2026-01-01
interest expense 192,700,000 FinanceCosts 2025-12-31
ocf 692,200,000 CashFlowsFromUsedInOperatingActivities 2025-12-31
revenue 2,967,500,000 RevenueFromContractsWithCustomers 2025-12-31

The ratios

The figures themselves rather than their scores — what somebody looking up DIM.PA on one particular measure came for.

RatioValue
cash operating margin17.72
current ratio1.02
current ratio reported1.02
ev ebit39.46
ev owner earnings29.97
ev sales6.99
fcf margin23.33
interest cover2.73
net debt ebitda2.74
operating margin17.72
owner earnings margin23.33
revenue growth6.74
revenue growth per share6.74
roic7.51
rule of 4024.46
sbc pct revenue0.0

What to be careful about

What this model itself distrusts about DIM.PA's figures. Written by the derivation as it ran, not added afterwards.